FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15236711000001104: Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2194781000001111 Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2194791000001113 Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Azacitidine 100mg powder for suspension for injection vials true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Azacitidine true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Vidaza true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Azacitidine true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has AMP True Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start